|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Coreg (carvedilol) Tablets, 3.125, 6.25, 12.5 and 25 mg GlaxoSmithKline NDA 20297/S011 9/29/03 9/30/03 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. GlaxoSmithKline NDA 20297/S009 3/27/03 4/1/03 7/8/03 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. GlaxoSmithKline NDA 20297/S007 11/1/01 3/28/02 3/28/02 3/28/02 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. SmithKline Beecham NDA 20297/S004 Carvedilol Tablets, TEVA Pharmaceuticals | Carvedilol Tablet, Ranbaxy, Tentative Approval | Coreg (carvedilol) Tablets, GlaxoSmithKline, New or Modified Indication | Coreg (carvedilol) Tablets, SmithKline Beecham, Labeling Revision | Carvedilol Tablets, Caraco Pharma, Tentative Approval | Carvedilol Tablets, Watson Labs, Tentative Approval | Carvedilol Tablets, Caraco Pharma, Tentative Approval | Carvedilol Tablets, Mylan Pharma, Tentative Approval | Carvedilol Tablets, Zydus Pharma, Tentative Approval | Carvedilol Tablets, Taro Pharma, Tentative Approval | Coreg Tablet, Glaxosmithkline, Labeling Revision | Coreg (carvedilol) Tablets, GlaxoSmithKline, Labeling Revision | Coreg CR (carvedilol phosphate) Extended-Release Capsules, GlaxoSmithKline, Approval | Carvedilol Tablets, Hikma Pharma, Tentative Approval | Coreg (carvedilol) Tablets, GlaxoSmithKline, Labeling Revision | Coreg (carvedilol) Tablets, GlaxoSmithKline, Patient Population Altered
|